Network meta-analysis of MS DMTs: In response to "Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis" by Chen et al.

MLA

Jomaa, Khalil, et al. “Network Meta-Analysis of MS DMTs: In Response to ‘Comparative Efficacy and Safety of Disease-Modifying Therapies in Patients with Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-Analysis’ by Chen et Al.” Journal of the American Pharmacists Association : JAPhA, vol. 64, no. 1, Jan. 2024, pp. 27–28. EBSCOhost, https://doi.org/10.1016/j.japh.2023.07.006.

APA

Jomaa, K., Gianinazzi, M., Guerra, A., Shen, C., & Debray, T. (2024). Network meta-analysis of MS DMTs: In response to “Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis” by Chen et al. Journal of the American Pharmacists Association : JAPhA, 64(1), 27–28. https://doi.org/10.1016/j.japh.2023.07.006

Chicago

Jomaa, Khalil, Mattia Gianinazzi, Angela Guerra, Changyu Shen, and Thomas Debray. 2024. “Network Meta-Analysis of MS DMTs: In Response to ‘Comparative Efficacy and Safety of Disease-Modifying Therapies in Patients with Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-Analysis’ by Chen et Al.” Journal of the American Pharmacists Association : JAPhA 64 (1): 27–28. doi:10.1016/j.japh.2023.07.006.